Accelerate Diagnostics (STU:1A80) FCF Margin % : -306.96% (As of Mar. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Accelerate Diagnostics FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Accelerate Diagnostics's Free Cash Flow for the three months ended in Mar. 2024 was €-8.25 Mil. Accelerate Diagnostics's Revenue for the three months ended in Mar. 2024 was €2.69 Mil. Therefore, Accelerate Diagnostics's FCF Margin % for the quarter that ended in Mar. 2024 was -306.96%.

As of today, Accelerate Diagnostics's current FCF Yield % is -187.78%.

The historical rank and industry rank for Accelerate Diagnostics's FCF Margin % or its related term are showing as below:

STU:1A80' s FCF Margin % Range Over the Past 10 Years
Min: -26382.31 Med: -956.54 Max: -302.52
Current: -302.52

During the past 13 years, the highest FCF Margin % of Accelerate Diagnostics was -302.52%. The lowest was -26382.31%. And the median was -956.54%.

STU:1A80's FCF Margin % is ranked worse than
86.11% of 828 companies
in the Medical Devices & Instruments industry
Industry Median: -7.525 vs STU:1A80: -302.52

Accelerate Diagnostics FCF Margin % Historical Data

The historical data trend for Accelerate Diagnostics's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Accelerate Diagnostics FCF Margin % Chart

Accelerate Diagnostics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

-700.51

-463.54

-406.78

-386.46

-341.92

Accelerate Diagnostics Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
FCF Margin %	Get a 7-Day Free Trial															-475.86	-375.78	-273.15	-259.80	-306.96

Competitive Comparison of Accelerate Diagnostics's FCF Margin %

For the Medical Devices subindustry, Accelerate Diagnostics's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Accelerate Diagnostics's FCF Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Accelerate Diagnostics's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Accelerate Diagnostics's FCF Margin % falls into.

Accelerate Diagnostics FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Accelerate Diagnostics's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-37.809	/	11.058
	=	-341.92 %

Accelerate Diagnostics's FCF Margin for the quarter that ended in Mar. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Mar. 2024 )	/	Revenue (Q: Mar. 2024 )
	=	-8.248	/	2.687
	=	-306.96 %

Accelerate Diagnostics FCF Margin % Related Terms

Thank you for viewing the detailed overview of Accelerate Diagnostics's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Accelerate Diagnostics (STU:1A80) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Accelerate Diagnostics Inc (STU:1A80) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

AXDX:USA AXDX:Mexico 1A80:Germany

Address

3950 South Country Club Road, Suite 470, Tucson, AZ, USA, 85714

Website

https://www.acceleratediagnostics.com

Accelerate Diagnostics Inc is an in vitro diagnostics company that specializes in rapid diagnostics for infectious pathogens. The firm's core platform, the Accelerate ID/AST System, determines whether live bacterial or fungal cells in a patient sample are susceptible to a particular antibiotic. This test is performed on pathogens that are commonly associated with serious infections and can deliver results more quickly than traditional methods, such as bacterial culturing. The system can analyze a positive blood culture sample in approximately five hours, which is faster than traditional testing techniques. The company earns majority of its revenue from domestic market.

Accelerate Diagnostics (STU:1A80) Headlines

No Headlines